中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [12]
采集方式
OAI收割 [12]
内容类型
期刊论文 [12]
发表日期
2021 [1]
2020 [2]
2019 [1]
2018 [3]
2017 [1]
2016 [1]
更多
学科主题
筛选
浏览/检索结果:
共12条,第1-10条
帮助
限定条件
专题:上海药物研究所
第一署名单位
第一作者单位
通讯作者单位
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Twin drug design, synthesis and evaluation of diosgenin derivatives as multitargeted agents for the treatment of vascular dementia
期刊论文
OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 卷号: 37, 页码: 16
作者:
Yang, Gui-Xiang
;
Sun, Jia-Min
;
Zheng, Lu-Lu
;
Zhang, Li
;
Li, Jie
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2021/06/11
Vascular dementia
Diosgenin
Antioxidant
Anti-cholinesterase
Multi-target-directed ligands
Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function
期刊论文
OAI收割
MOLECULAR CANCER THERAPEUTICS, 2020, 卷号: 19, 期号: 11, 页码: 2340-2352
作者:
Jin, Rui
;
Liu, Liang
;
Xing, Yun
;
Meng, Tao
;
Ma, Lanping
  |  
收藏
  |  
浏览/下载:61/0
  |  
提交时间:2020/12/24
Species differences in the CYP3A-catalyzed metabolism of TPN729, a novel PDE5 inhibitor
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 9
作者:
Tian, Qian-qian
;
Zhu, Yun-ting
;
Diao, Xing-xing
;
Zhang, Xiang-lei
;
Xu, Ye-chun
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2020/12/24
PDE5 inhibitor
TPN729
M3
species difference
pharmacokinetics
metabolite identification
Exploration of the structure-activity relationship and druggability of novel oxazolidinone-based compounds as Gram-negative antibacterial agents
期刊论文
OAI收割
ARCHIV DER PHARMAZIE, 2019, 页码: 13
作者:
Ding, Shi
;
Ji, Jing-Chao
;
Zhang, Ming-Juan
;
Yang, Yu-She
;
Wang, Rui
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2020/07/01
antibacterial activity
oxazolidine
QSAR
Discovery of novel selective GPR120 agonists with potent anti-diabetic activity by hybrid design
期刊论文
OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 卷号: 28, 期号: 15, 页码: 2599-2604
作者:
Sheng, Ren
;
Yang, Liu
;
Zhang, Yanchun
;
Xing, Enming
;
Shi, Rui
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2019/01/08
GPR120
Agonist biphenyl derivatives
OGTT
Type 2 diabetes
Activation of AhR with nuclear IKK alpha regulates cancer stem-like properties in the occurrence of radioresistance
期刊论文
OAI收割
CELL DEATH & DISEASE, 2018, 卷号: 9
作者:
Yan, Bin
;
Liu, Shuang
;
Shi, Ying
;
Liu, Na
;
Chen, Ling
  |  
收藏
  |  
浏览/下载:108/0
  |  
提交时间:2019/01/08
Isolation, identification and bioactivities of abietane diterpenoids from Premna szemaoensis
期刊论文
OAI收割
RSC ADVANCES, 2018, 卷号: 8, 期号: 12, 页码: 6425-6435
作者:
Pu, De-Bing
;
Wang, Ting
;
Zhang, Xing-Jie
;
Gao, Jun-Bo
;
Zhang, Rui-Han
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/01/08
Dissociative role for dorsal hippocampus in mediating heroin self-administration and relapse through CDK5 and RhoB signaling revealed by proteomic analysis
期刊论文
OAI收割
ADDICTION BIOLOGY, 2017, 卷号: 22, 期号: 6, 页码: 1731-1742
作者:
Chen, Zhong-Guo
;
Liu, Xing
;
Wang, Weisheng
;
Geng, Fan
;
Gao, Jing
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2019/01/08
CDK5
dorsal hippocampus
heroin self-administration
label-free proteomic analysis
RhoB
the centrifugal proteomic reactor
Discovery and structural optimization of 4-(4-(benzyloxy) phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 11, 页码: 1516
作者:
Wu Xishan
;
Wang Rui
;
Xing Yanli
;
Xue Xiaoqian
;
Zhang Yan
  |  
收藏
  |  
浏览/下载:83/0
  |  
提交时间:2020/12/24
GAMMA-T
ORPHAN RECEPTORS
CELL-DIFFERENTIATION
LIGAND
IDENTIFICATION
MODULATORS
DERIVATIVES
PROTEIN
INHIBITORS
DOCKING
nuclear receptor
RORc
inverse agonist
SAR
structure-based optimization
autoimmune disease
Epirubicin-Loaded Superparamagnetic Iron-Oxide Nanoparticles for Transdermal Delivery: Cancer Therapy by Circumventing the Skin Barrier
期刊论文
OAI收割
SMALL, 2015, 卷号: 11, 期号: 2, 页码: 239-247
作者:
Rao, Yue-feng
;
Chen, Wei
;
Liang, Xing-guang
;
Huang, Yong-zhuo
;
Miao, Jing
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/01/08
superparamagnetic materials
iron oxide
nanoparticles
drug delivery
epirubicin
cancer
biomedical applications